Metchnikoff emphasized cellular defense
Metchnikoff's work on phagocytosis made cells active agents in immune response. His model focused attention on how organisms respond to invading microbes through living cellular action.
Timeline Entry
Ehrlich and Metchnikoff's Nobel Prize, 1908
In 1908 the Nobel Prize in Physiology or Medicine was awarded jointly to Paul Ehrlich and Elie Metchnikoff for work on immunity. The award placed competing theories of immune defense inside a single public story of modern biological medicine.
The prize matters because it marked immunology as a field built from both cellular and chemical explanations, linking bacteriology, serum therapy, laboratory experimentation, and later vaccine and drug research.
Historical Significance
Immunity became a laboratory science with rival models
Ehrlich emphasized chemical specificity
Ehrlich's side-chain theory treated immunity through binding, receptors, toxins, antitoxins, and specificity. This language helped shape later thinking about antibodies and targeted therapy.
The award joined bacteriology to therapy
Immunology grew from the world of Robert Koch, serum therapy, diphtheria antitoxin, and experimental pathology. The Nobel Prize made those linked fields visible as a modern medical frontier.
Reading Path
Where this entry fits
Read this entry with Paul Ehrlich, Robert Koch, History of Vaccination, and History of Antibiotics and Penicillin to follow the movement from microbes to immunity and therapeutic specificity.